[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL138624A0 - Nucleic acid transfer vectors, compositions containing same and uses - Google Patents

Nucleic acid transfer vectors, compositions containing same and uses

Info

Publication number
IL138624A0
IL138624A0 IL13862499A IL13862499A IL138624A0 IL 138624 A0 IL138624 A0 IL 138624A0 IL 13862499 A IL13862499 A IL 13862499A IL 13862499 A IL13862499 A IL 13862499A IL 138624 A0 IL138624 A0 IL 138624A0
Authority
IL
Israel
Prior art keywords
nucleic acid
compositions containing
transfer vectors
containing same
acid transfer
Prior art date
Application number
IL13862499A
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9803573A external-priority patent/FR2776669B1/en
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL138624A0 publication Critical patent/IL138624A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/15Nucleic acids forming more than 2 strands, e.g. TFOs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL13862499A 1998-03-24 1999-03-19 Nucleic acid transfer vectors, compositions containing same and uses IL138624A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9803573A FR2776669B1 (en) 1998-03-24 1998-03-24 NUCLEIC ACID TRANSFER VECTORS, COMPOSITIONS CONTAINING SAME, AND USES THEREOF
US8584898P 1998-05-18 1998-05-18
PCT/FR1999/000643 WO1999049067A1 (en) 1998-03-24 1999-03-19 Nucleic acid transfer vectors, compositions containing same and uses

Publications (1)

Publication Number Publication Date
IL138624A0 true IL138624A0 (en) 2001-10-31

Family

ID=26234216

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13862499A IL138624A0 (en) 1998-03-24 1999-03-19 Nucleic acid transfer vectors, compositions containing same and uses

Country Status (12)

Country Link
EP (1) EP1066396A1 (en)
JP (1) JP2002507429A (en)
KR (1) KR20010074456A (en)
CN (1) CN1292827A (en)
AU (1) AU758406B2 (en)
BR (1) BR9909044A (en)
CA (1) CA2323831A1 (en)
HU (1) HUP0102413A3 (en)
IL (1) IL138624A0 (en)
NO (1) NO20004648L (en)
PL (1) PL342944A1 (en)
WO (1) WO1999049067A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60132200T2 (en) * 2000-05-26 2008-12-18 Centelion PURIFICATION OF A TRIPELHELIC INFORMATION BY IMMOBILIZED OLIGONUCLEOTIDE
FR2871465B1 (en) * 2004-06-15 2006-09-08 Centre Nat Rech Scient Cnrse COLLECTIONS OF TRACEABLE COMPOUNDS AND USES THEREOF
WO2006133099A2 (en) * 2005-06-03 2006-12-14 The Cbr Institute For Biomedical Research, Inc. Sirna microbicides for preventing and treating viral diseases
US7795380B2 (en) 2006-06-02 2010-09-14 University Of Iowa Research Foundation Compositions and methods for nucleic acid delivery
WO2017156038A2 (en) * 2016-03-07 2017-09-14 Alere San Diego, Inc. Immunoassay controls and the use thereof
RU2731513C2 (en) * 2018-12-21 2020-09-03 Селл энд Джин Терапи Лтд Gene-therapeutic dna-vector based on gene-therapeutic dna-vector vtvaf17, carrying target gene selected from group of genes nos2, nos3, vip, kcnma1, cgrp, to increase expression level of these target genes, method for production and use thereof, strain escherichia coli scs110-af/vtvaf17-nos2, or escherichia coli scs110-af/vtvaf17-nos3, or escherichia coli scs110-af/vtvaf17-vip, or escherichia coli scs110-af/vtvaf17-kcnma1, or escherichia coli scs110-af/vtvaf17-cgrp, carrying gene-therapeutic dna vector, method for production thereof, method for industrial production of gene-therapeutic dna vector
WO2024206118A1 (en) * 2023-03-24 2024-10-03 Yarrow Therapeutics, Inc. Nuclear localization polypeptides and conjugates and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020698A1 (en) * 1991-05-17 1992-11-26 Uab Research Foundation Sequence specific dna binding drugs
US5670347A (en) * 1994-05-11 1997-09-23 Amba Biosciences Llc Peptide-mediated gene transfer
FR2731014B1 (en) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa DNA MOLECULES, PREPARATION AND USE IN GENE THERAPY

Also Published As

Publication number Publication date
EP1066396A1 (en) 2001-01-10
JP2002507429A (en) 2002-03-12
NO20004648D0 (en) 2000-09-18
KR20010074456A (en) 2001-08-04
NO20004648L (en) 2000-09-18
HUP0102413A3 (en) 2003-09-29
WO1999049067A1 (en) 1999-09-30
CA2323831A1 (en) 1999-09-30
PL342944A1 (en) 2001-07-16
BR9909044A (en) 2000-12-05
CN1292827A (en) 2001-04-25
AU3406200A (en) 2000-12-14
HUP0102413A1 (en) 2001-10-28
AU758406B2 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
AU2105999A (en) Novel quaternary ammonium compounds, compositions containing them, and uses thereof
EP1133572A4 (en) Chlamydia pneumoniae genome sequence
GB2361904B (en) Transfer system
IL162274A (en) Nucleic acid and protein designated 193p1e1b and compositions containing the same
EP1117436A4 (en) Neisseria spp polypeptide, nucleic acid sequence and uses thereof
PL339920A1 (en) Synergetic compositions comprising oxathiazine and benzothiophene-2-carboxamido-s,s-dioxide
PL342944A1 (en) Nucleic acid transfer vectors, compositions containing same and uses
IL148805A0 (en) Gene transfer vectors
PL348513A1 (en) Novel nucleic acid transferring agents, compositions containing them and uses
EP1208268A4 (en) Novel quaternary compounds, compositions containing them, and uses thereof
GB9704643D0 (en) Chemical composition
PL342886A1 (en) Novel nucleic acid transfer agents, compositions containing same and uses
GB9817909D0 (en) DNA constructs
AU1728197A (en) Lipopolyamine compound, pharmaceutical composition and nucleic acid transfer vector containing same, and preparation method
ZA992262B (en) Vectors for transferring nucleic acids, compositions containing them and their uses.
GB9813381D0 (en) Paitent transfer aid
HUP0003585A3 (en) Gene coding for androctonine, vector containing same and transformed disease-resistant plants obtained
GB9813380D0 (en) Paitent transfer aid
AU7790300A (en) Cd29 pig protein, nucleic acid coding for said protein and the applications thereof
GB9819600D0 (en) Chemical compositions
EP1285942A4 (en) Polypeptide derivatives and nucleic acid carriers containing the same
IL142278A0 (en) Imidazo-isoquinoline compounds, their compositions and uses
GB9822216D0 (en) Gene transfer
AUPP704498A0 (en) Nucleic acid sequence
HUP0101911A3 (en) Novel sequence class of genes, corresponding proteins and the use of the same